{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-027482","form_type":"8-K","ticker":"NVNO","cik":"0001661053","company_name":"enVVeno Medical Corp","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.069122+00:00","generated_at":"2026-05-16T13:21:47.195654+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"enVVeno stockholders reject 2025 equity plan; authorize reverse stock split","bullets":["Elected Jenusaitis (3.47M for, 1.80M withheld) and Berman (4.73M for, 0.54M withheld) as Class II directors.","Advisory say-on-pay passed: 3.19M for, 1.96M against, 5.79M broker non-votes.","Stockholders voted AGAINST the 2025 Equity Incentive Plan (2.48M for, 2.62M against); 2016 plan remains.","Approved reverse stock split authorization (7.31M for, 1.58M against) at ratio of 1:5 to 1:35 at Board discretion.","Ratified CBIZ CPAs P.C. as auditor for FY2025 (10.86M for, 0.14M against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-027482","json":"https://secwatch.observer/filing/0001493152-25-027482.json","markdown":"https://secwatch.observer/filing/0001493152-25-027482.md","text":"https://secwatch.observer/filing/0001493152-25-027482.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225027482/0001493152-25-027482-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225027482/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:21:47.195654+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}